Annual ROE
-69.87%
+3.74%+5.08%
31 December 2023
Summary:
Corvus Pharmaceuticals annual return on equity is currently -69.87%, with the most recent change of +3.74% (+5.08%) on 31 December 2023. During the last 3 years, it has fallen by -25.37% (-57.01%). CRVS annual ROE is now -169.35% below its all-time high of 100.75%, reached on 31 December 2015.CRVS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-167.55%
-113.56%-210.34%
30 September 2024
Summary:
Corvus Pharmaceuticals quarterly return on equity is currently -167.55%, with the most recent change of -113.56% (-210.34%) on 30 September 2024. Over the past year, it has dropped by -107.92% (-180.98%). CRVS quarterly ROE is now -250.81% below its all-time high of 111.10%, reached on 31 December 2015.CRVS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRVS ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -181.0% |
| 3 y3 years | -57.0% | -280.8% |
| 5 y5 years | -6.5% | -206.8% |
CRVS ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -57.0% | +5.1% | -326.6% | at low |
| 5 y | 5 years | -740.8% | +5.1% | -2243.4% | at low |
| alltime | all time | -169.3% | +5.1% | -250.8% | at low |
Corvus Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -167.55%(+210.3%) |
| June 2024 | - | -53.99%(-10.0%) |
| Mar 2024 | - | -59.96%(+0.6%) |
| Dec 2023 | -69.87%(-5.1%) | -59.63%(-1.9%) |
| Sept 2023 | - | -60.76%(-14.7%) |
| June 2023 | - | -71.23%(+8.9%) |
| Mar 2023 | - | -65.40%(+15.1%) |
| Dec 2022 | -73.61%(+65.4%) | -56.80%(+15.7%) |
| Sept 2022 | - | -49.08%(+24.9%) |
| June 2022 | - | -39.28%(-4.5%) |
| Mar 2022 | - | -41.15%(-6.5%) |
| Dec 2021 | -44.50%(+435.5%) | -44.00%(+507.7%) |
| Sept 2021 | - | -7.24%(-4.4%) |
| June 2021 | - | -7.57%(+5.9%) |
| Mar 2021 | - | -7.15%(-32.8%) |
| Dec 2020 | -8.31% | -10.64%(-86.6%) |
| Sept 2020 | - | -79.15%(+13.9%) |
| June 2020 | - | -69.51%(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -63.69%(+16.6%) |
| Dec 2019 | -65.63%(+54.3%) | -54.61%(+12.8%) |
| Sept 2019 | - | -48.42%(+11.3%) |
| June 2019 | - | -43.50%(+12.3%) |
| Mar 2019 | - | -38.73%(+1.9%) |
| Dec 2018 | -42.54%(-35.2%) | -38.02%(-8.0%) |
| Sept 2018 | - | -41.31%(-9.5%) |
| June 2018 | - | -45.65%(-11.0%) |
| Mar 2018 | - | -51.29%(-7.5%) |
| Dec 2017 | -65.61%(+139.5%) | -55.44%(+13.7%) |
| Sept 2017 | - | -48.78%(+16.1%) |
| June 2017 | - | -42.03%(+24.5%) |
| Mar 2017 | - | -33.75%(+34.6%) |
| Dec 2016 | -27.39%(-127.2%) | -25.08%(-16.7%) |
| Sept 2016 | - | -30.10%(-22.8%) |
| June 2016 | - | -38.99%(-65.1%) |
| Mar 2016 | - | -111.62%(-200.5%) |
| Dec 2015 | 100.75% | 111.10%(+11.2%) |
| Sept 2015 | - | 99.94% |
FAQ
- What is Corvus Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly ROE year-on-year change?
What is Corvus Pharmaceuticals annual return on equity?
The current annual ROE of CRVS is -69.87%
What is the all time high annual ROE for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual return on equity is 100.75%
What is Corvus Pharmaceuticals quarterly return on equity?
The current quarterly ROE of CRVS is -167.55%
What is the all time high quarterly ROE for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly return on equity is 111.10%
What is Corvus Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, CRVS quarterly return on equity has changed by -107.92% (-180.98%)